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        Induction of tyrosine phosphorylation by the 
TCR is essential for proliferation and diff  er-
entiation of resting T cells into eff  ector cells. 
One of the earliest intracellular modifi  cations 
of downstream TCR recognition is the activa-
tion of the src family kinase Lck, which phos-
phorylates tyrosine residues of CD3, ZAP-70, 
and other substrates that initiate signaling cas-
cades leading to T cell activation and prolifera-
tion (  1  ). In the absence of Lck, the TCR fails 
to induce any tyrosine phosphorylation and all 
downstream signaling events are blocked (  2, 3  ). 
Lck is predominantly associated with the cyto-
solic side of the plasma membrane, a localiza-
tion which is consistent with its importance in 
the early signaling events involving the TCR (  4  ). 
The N-terminal Gly-Cys-Val-Cys sequence of 
Lck is modifi  ed by the addition of myristate 
and palmitate to the glycine and the two cyste-
ine residues, respectively (  5  ). Transport of Lck 
to the plasma membrane relies on the exocytic 
pathway (  6  ) and requires acylation of its N-ter-
minal sequence (  7  ). Lck acylation is also essential 
for activation of downstream signaling path-
ways (  7  ) and partitioning into detergent-resis-
tant membranes (  5  ) that are postulated to contain 
specialized membrane microdomains ( 8  ). Given 
the importance of Lck, the characterization of 
the cellular and molecular mechanisms that gov-
ern its transport to the plasma membrane is 
essential for understanding its function and dy-
namics. Although much is known about the 
biochemical regulation of Lck, very little is known 
about the protein machinery involved in the 
targeting of Lck to the T cell plasma membrane. 
  MAL is a 17-kD integral membrane protein 
containing a MARVEL (MAL and related pro-
teins for vesicle traffi   cking and membrane link) 
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  The MAL protein is an essential component of the specialized machinery for apical target-
ing in epithelial cells. The src family kinase Lck plays a pivotal role in T cell signaling. We 
show that MAL is required in T cells for effi  cient expression of Lck at the plasma mem-
brane and activation of   IL-2   transcription. To investigate the mechanism by which MAL 
regulates Lck targeting, we analyzed the dynamics of Lck and found that it travels to the 
plasma membrane in specifi  c transport carriers containing MAL. Coimmunoprecipitation 
experiments indicated an association of MAL with Lck. Both carrier formation and parti-
tioning of Lck into detergent-insoluble membranes were ablated in the absence of MAL. 
Polarization of T cell receptor for antigen (TCR) and microtubule-organizing center to 
immunological synapse (IS) were also defective. Although partial correction of the latter 
defects was possible by forced expression of Lck at the plasma membrane, their complete 
correction, formation of transport vesicles, partitioning of Lck, and restoration of signaling 
pathways, which are required for   IL-2   transcription up-regulation, were achieved by exog-
enous expression of MAL. We concluded that MAL is required for recruitment of Lck to 
specialized membranes and formation of specifi  c transport carriers for Lck targeting. This 
novel transport pathway is crucial for TCR-mediated signaling and IS assembly. 
© 2008 Antón et al.  This article is distributed under the terms of an Attribu-
tion–Noncommercial–Share Alike–No Mirror Sites license for the fi  rst six months 
after the publication date (see http://www.jem.org/misc/terms.shtml). After six 
months it is available under a Creative Commons License (Attribution–Noncom-
mercial–Share Alike 3.0 Unported license, as described at http://creativecommons
.org/licenses/by-nc-sa/3.0/).3202 A NOVEL PATHWAY FOR LCK EXOCYTOSIS IN T CELLS   | Ant  ó  n et al. 
The procedure used was similar to that previously described 
for the generation and selection of mutants defective in 
PMA-induced CD69 up-regulation (  18, 19  ). The reduced 
MAL mRNA expression in this clone was further confi  rmed 
by Northern blot and quantitative RT-PCR analyses (Fig. S1, 
A and B, available at http://www.jem.org/cgi/content/full/
domain present in proteins associated with membrane juxtapo-
sition events (  9  ) such as synaptophysins, synaptogyrins, and oc-
cludin (  9  ). The MAL cDNA, which was initially characterized 
as being diff  erentially expressed in Jurkat cells and other T cell 
lines, but not in B cell lines (  10  ), is also expressed in polarized 
epithelial cells. MAL is selectively detected in detergent-resis-
tant membrane fractions of epithelial cells, Jurkat cells, and 
PBLs (  11, 12  ). Although the function of MAL in epithelial 
cells as an essential component of the machinery for specialized 
protein exocytosis to the apical surface is well established 
(  12  –  14  ), its function in T cells has remained merely a matter of 
speculation (  15  ). 
  In response to appropriate antigens presented by an APC, 
TCR-induced signals assemble a sophisticated apparatus for 
ongoing signaling (  1  ) and induce T cells to polarize and form a 
surface subdomain at the T cell  –  APC contact zone, known as 
the immunological synapse (IS) (  16  ). The formation of an IS is 
a dynamic process that involves polarization of TCR, Lck, and 
other signaling machinery, microtubule-organizing center 
(MTOC), integrin LFA-1, and actin cytoskeleton (  16  ). The 
Jurkat T cell line and mutant derivatives have been important 
tools for investigating TCR-driven signaling and polarization 
(  17  ). In this study, we have used MAL knockdown experi-
ments involving short interfering RNA (siRNA) expression in 
Jurkat cells and primary T lymphocytes and a novel TCR sig-
naling  –  defective Jurkat cell clone lacking MAL expression to 
investigate the role of MAL in T cells. Time-lapse videomi-
croscopy showed that Lck reaches the plasma membrane in 
transport carriers containing MAL. The formation of the carri-
ers, as well as the partitioning of Lck into detergent-resistant 
membranes, was blocked in the absence of MAL expression, 
resulting in intracellular accumulation of Lck. The formation 
of transport carriers for Fyn or p75 was not aff  ected under 
those conditions. Probably as a consequence of the depletion 
of Lck at the plasma membrane, polarized assembly of TCR 
and Lck to the IS and activation of the signaling pathways lead-
ing to IL-2 gene transcription were both impaired. Exogenous 
expression of MAL fully corrects all the functional defects ob-
served in the absence of MAL expression including formation 
of Lck transport carriers, partitioning of Lck, and IL-2 pro-
moter activation. Therefore, MAL, which was found to associ-
ate with Lck, has an essential role mediating the targeting of 
Lck to the T cell plasma membrane by allowing recruitment of 
Lck to specialized intracellular membrane microdomains and 
formation of specifi  c transport carriers destined for the plasma 
membrane. This novel transport pathway is crucial for TCR-
mediated signaling and IS formation. 
    RESULTS   
  Polarized targeting to the IS is defi  cient when MAL 
is not expressed 
  During a screening program involving the analysis of cDNA 
microarrays to identify novel Jurkat T cell mutants with de-
fective TCR-induced signaling, a cell clone known as Jurkat 
TCR-signaling impaired mutant (JTIM) with no detectable 
MAL messenger RNA (mRNA) expression was isolated. 
    Figure 1.         MAL expression is required for translocation of TCR and 
reorientation of MTOC to IS.   (A) Normal Jurkat cells, JTIM cells, and 
JTIM/MAL cells were extracted with 1% Triton X-100 at 4  °  C. The soluble 
(S) and insoluble (I) fractions were isolated by centrifugation to equilib-
rium in sucrose density gradients. Equivalent aliquots from both fractions 
were analyzed by immunoblotting with anti-MAL mAb 6D9. The distribu-
tions of CD59 and TfR, as respective markers of the insoluble and soluble 
fractions, were analyzed as a control of the fractionation procedure. 
(B and C) Cells were conjugated to SEE-pulsed APCs for 15 min. After cell 
fi  xation, the distribution of TCR, ICAM-3, and PKC-     (B) and that of actin, 
talin, and     -tubulin (C) were analyzed in nonpermeabilized or permeabi-
lized cells, respectively. The arrows indicate the position of the MTOC in 
the T cell. (D) The mean percentage   ±   SEM of Jurkat cells in T cell  –  APC 
conjugates with polarized distribution of TCR, actin, and MTOC to the IS 
was quantifi  ed in three independent experiments.   n    >   100  T  cells/experi-
ment (right). Bars, 5   μ  m.     JEM VOL. 205, December 22, 2008 
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    , and MTOC to the IS in response to stimulation, whereas 
ICAM-3, actin, and talin distributed to the IS normally (  Fig. 1, 
B  –  D  ). In addition, JTIM cells failed to target ZAP-70 and 
LAT to the IS (Fig. S2). It is of particular note that stable ex-
ogenous expression of MAL in JTIM cells restored the IS 
polarization pattern observed in normal Jurkat cells (  Fig. 1, 
B  –  D   and Fig. S2). 
  To confi  rm that MAL is required for normal IS forma-
tion, we used an RNA interference knockdown approach. 
For this purpose, we expressed siRNAs (MAL siRNA1 and 2) 
targeted to a region adjacent to the AUG translation initia-
tion site (MAL siRNA1) or to the 3     untranslated region 
jem.20080552/DC1).   Fig. 1 A   confi  rms that JTIM cells do 
not express detectable levels of MAL, whereas the expression 
of MAL and its partition in detergent-insoluble membrane 
fractions were similar in normal Jurkat cells and JTIM cells in 
which MAL expression was reconstituted by stable transfec-
tion of MAL cDNA (JTIM/MAL cells).   JTIM cells estab-
lished T cell  –  APC conjugates either in the presence or 
absence of staphylococcal enterotoxin E (SEE) superantigen 
with the same effi   ciency as normal Jurkat cells (Fig. S1C), al-
lowing investigation of the possible requirement of MAL for 
targeting of receptors, cytoskeleton, and signaling molecules 
to IS. JTIM cells were unable to translocate the TCR, PKC-
    Figure 2.         Effect of MAL knockdown on IS formation in Jurkat cells and primary T lymphocytes.   (A) Jurkat cells were transfected with DNA con-
structs expressing GFP and a control (c) siRNA or the indicated MAL siRNA and incubated for 48 h at 37  °  C. GFP-expressing cells were separated in a cell 
sorter and analyzed for MAL expression by immunoblotting with anti-MAL mAb 6D9. (B) Normal Jurkat cells or Jurkat cells stably expressing either MAL/myc 
or MALmut/myc were transfected with pMAL-siRNA1/GFP or pMAL-siRNA2/GFP, as indicated. After 48 h at 37  °  C, cells were conjugated to SEE-loaded Raji 
cells for 20 min and fi  xed. The distribution of TCR and MTOC was determined by immunofl  uorescence analysis. The arrows indicate the position of the MTOC 
in the T cell. A quantitative analysis of the effect of MAL siRNA expression on MTOC reorientation is shown in the histogram. (C) Jurkat CH7C17 cells express-
ing GFP and a control siRNA or MAL siRNA1 for 48 h at 37  °  C were conjugated to either SEB or HA peptide  –  loaded HOM2 cells for 20 min and fi  xed. The dis-
tribution of TCR was determined by immunofl  uorescence analysis. (D) Human PBLs were transfected with plasmid DNA expressing GFP and a control siRNA 
or MAL siRNA1 and incubated for 36 h at 37  °  C. Cells were then conjugated to SEE-loaded APCs for 15 min. After cell fi  xation, the distribution of TCR, PKC-   , 
and ICAM-3 was determined by immunofl  uorescence analysis. The histograms show the mean   ±   SEM of the percentage of APC-conjugated GFP-expressing 
T cells with MTOC (B) or TCR (C and D) polarized to the IS. Three independent experiments were performed.   n    >   100  T  cells/experiment.  Bars,  5   μ m.   3204 A NOVEL PATHWAY FOR LCK EXOCYTOSIS IN T CELLS   | Ant  ó  n et al. 
with the predominant exclusion of Lck from detergent-insol-
uble membranes (  Fig. 3 C  ). This implies that MAL expres-
sion in Jurkat cells is necessary for both effi   cient Lck targeting 
to the plasma membrane and normal partitioning into deter-
gent-insoluble membrane fractions. Neither the partitioning 
of LAT (  Fig. 3 C  ) and CD59 (  Fig. 1 A  ) nor their targeting at 
the cell surface was aff  ected by the absence of MAL (Fig. S2 
and not depicted). Pulse-chase experiments revealed that al-
though Lck was already associated with membranes in normal 
and JTIM cells 15 min after its biosynthesis, incorporation of 
Lck into detergent-insoluble membranes was only observed 
in normal cells (Fig. S3). As occurred with the TCR, Lck did 
not redistribute to the IS in T cell  –  APC conjugates formed 
using JTIM cells (  Fig. 3 D  ). The observation that the levels of 
Lck into detergent-insoluble membranes strictly correlated 
with MAL expression prompted us to analyze whether MAL 
associates with Lck. Coimmunoprecipitation experiments us-
ing Jurkat MAL/myc cells indicated association of MAL with 
endogenous Lck (  Fig. 3 E  , left). This association was also de-
tected in COS-7 cells transiently expressing both proteins 
(  Fig. 3 E  , right). The interaction was mapped to the amino 
terminus of Lck, as demonstrated by coimmunoprecipitation 
of MAL with a chimera consisting of the membrane proximal 
10-aa sequence of Lck fused to GFP (Lck  10  -GFP). As con-
trols, we observed that neither the p75-GFP chimera nor 
GFP coimmunoprecipitated with MAL (  Fig. 3 E  , right). 
  To address whether impaired IS assembly in JTIM cells was 
caused by the low levels of Lck at the cell periphery, JTIM cells 
were forced to express Lck at the plasma membrane by trans-
fecting DNA constructs encoding CD4/Lck or LAT/Lck chi-
meras, consisting of the extracellular and transmembrane 
domains of mouse CD4 or human LAT, respectively, fused to 
the amino terminus of Lck. The use of the CD4 and LAT trans-
membrane domains, which are predominantly excluded from 
or associated with detergent-insoluble membranes, respectively, 
allowed us to investigate whether the partitioning of Lck in this 
type of membrane infl  uences IS formation in the absence of 
MAL expression.   Fig. 4 (A  –  C)   shows that the expression of ei-
ther chimera in JTIM cells bypassed the requirement of MAL 
for targeting TCR, ZAP-70, and PKC-    , but not the MTOC, 
to the IS.   Furthermore, the chimeras were unable to rescue Erk 
activation (  Fig. 4 D  ), which was defi  cient in JTIM cells, and 
CD69 up-regulation (  Fig. 4 E  ), which is regulated by transcrip-
tion factor AP-1, in response to stimulation. 
  In summary, these data show that MAL regulates the tar-
geting of Lck to the plasma membrane, probably by allowing 
its inclusion in specialized membrane microdomains and that, 
although the absence of Lck at the plasma membrane is likely 
to be a major cause of the defects observed in MAL-depleted 
cells, it is not the sole cause because forced expression of Lck to 
the plasma membrane was not able to restore all the defects. 
  MAL is necessary for the formation of vesicular carriers 
that transport Lck to the plasma membrane 
  The requirement of MAL for Lck targeting to the T cell sur-
face prompted us to compare the distribution of these two 
(MAL siRNA2) of endogenous human MAL mRNA. To 
identify the transfected cell population, GFP was expressed 
from the same DNA constructs. Expression of MAL siRNA1 
and 2 was able to reduce endogenous MAL levels of Jurkat 
cells to   <  10% of the MAL content in cells expressing a con-
trol siRNA (  Fig. 2 A  ).   MAL knockdown in Jurkat cells reca-
pitulated the IS targeting defects observed in JTIM cells for 
TCR and MTOC (  Fig. 2 B  ), as well as for PKC-     (not de-
picted). To rule out possible spurious eff  ects of the siRNA, 
we used a stable clone of Jurkat cells (Jurkat MAL/myc cells) 
expressing MAL, tagged at its amino terminus with the Myc 
epitope encoded by a recombinant mRNA that does not 
fully pair with MAL siRNA1 (  12  ). The expression of MAL 
siRNA1 in these cells had no eff  ect on the polarization of 
TCR and MTOC to the IS because the exogenous protein 
was able to substitute the endogenous protein (  Fig. 2 B  ). As 
a further control we observed that the expression of a similar 
MAL protein (MALmut/myc) with a modifi  ed sequence at 
its carboxyl terminus (RWKSS  →  RWSSS), which is known 
to be inactive in polarized apical transport (  20  ), was unable to 
replace endogenous MAL (  Fig. 2 B  , histogram). 
  It is apparent that the eff  ect of MAL depletion on IS tar-
geting was not restricted to the use of the superantigen SEE, 
given that similar results were observed in T cell  –  APC conju-
gates formed with Jurkat CH7C17 cells (  21  ) in the presence of 
staphylococcal enterotoxin B or the infl   uenza HA peptide 
307  –  319 (  Fig. 2 C  ). Similar to the case of MAL-defi  cient Jur-
kat cells, expression of MAL siRNA in primary T lympho-
cytes resulted in an impaired translocation of TCR and PKC-   , 
but not of ICAM-3, to the IS (  Fig. 2 D  ). Thus, using Jurkat 
cells and primary T lymphocytes, we observed that normal IS 
formation is strictly dependent on MAL expression. 
  MAL is required for the targeting of Lck 
to the plasma membrane 
  In an attempt to identify proteins whose surface expression 
might be aff   ected in JTIM cells, we analyzed the plasma 
membrane distribution of TCR, ICAM-3, LAT, CD4, CD28, 
LFA-1, glycosylphosphatidylinositol-anchored proteins (CD59 
and CD55), and Lck at steady state. Among the molecules 
examined, there were proteins mostly detected in detergent-
insoluble membranes of resting T cells (LAT, CD59, CD55, 
and Lck) or predominantly excluded from these membrane 
fractions (TCR, ICAM-3, CD4, CD28, and LFA-1). Only in 
the case of Lck did we observe striking diff  erences in distribu-
tion between MAL-defi   cient and MAL-expressing Jurkat 
cells. Thus, although Lck was distributed at the cell periphery 
and in internal endosome structures in WT Jurkat and JTIM/
MAL cells, it was present only at very low levels at the plasma 
membrane and was largely concentrated in a compact intra-
cellular structure in most JTIM cells (  Fig. 3 A  ).   Consistent 
with the intracellular accumulation observed in JTIM cells, 
MAL siRNA expression diminished the expression of Lck at 
the cell periphery and led to its intracellular accumulation also 
in primary T lymphocytes (  Fig. 3 B  ). It is of particular note 
that the loss of peripheral Lck in JTIM cells was associated JEM VOL. 205, December 22, 2008 
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normal Jurkat and JTIM/MAL cells (  Fig. 5 B  ). To trace the 
formation and movement of Lck transport vesicles from the 
perinuclear region to the cell surface in living cells and to 
compare Lck dynamics with those of MAL, we transiently 
expressed Lck-Cherry in Jurkat cells stably expressing GFP-
MAL. The presence of the fl  uorescent protein moiety in MAL 
and Lck did not aff  ect either their partitioning into deter-
gent-insoluble membranes or their subcellular distribution 
(unpublished data). Time-lapse experiments showed that MAL 
and Lck travel in the same transport carriers destined for the 
molecules in Jurkat cells. As our anti-MAL mAb is not of use 
in immunofl  uorescence analysis, we used Jurkat cells stably 
expressing GFP-MAL. Confocal microscopic analysis shows 
that MAL and Lck colocalized extensively at these two loca-
tions (  Fig. 5 A  ).   Next, we studied the dynamics to investigate 
the possible involvement of MAL in Lck transport using a 
Lck-GFP chimera. As a control, we observed that transiently 
expressed Lck-GFP accumulated intracellularly in JTIM cells 
even more drastically than endogenous Lck, whereas Lck-
GFP was able to reach the plasma membrane effi   ciently in 
    Figure 3.         MAL is required for the targeting of Lck to the plasma membrane.   (A) The subcellular distribution of endogenous Lck was analyzed by 
indirect immunofl  uorescence in the three types of Jurkat cell. The percentage of cells with low levels of peripheral Lck are shown on the right and mea-
sured as described in Materials and methods. (B) Human PBLs were transfected with plasmid DNA expressing GFP and MAL siRNA1 and incubated for 36 h 
at 37  °  C. After cell fi  xation, the distribution of Lck was determined by immunofl  uorescence analysis in three independent experiments.   n    >   100  T  cells/
experiment. The histograms represent the mean percentage   ±   SEM of cells with predominant intracellular localization of Lck. (C) The soluble (S) and in-
soluble (I) membrane fractions of resting normal Jurkat cells, JTIM cells, and JTIM/MAL cells were isolated by centrifugation to equilibrium. Equivalent 
aliquots from both fractions were then analyzed by immunoblotting to detect endogenous Lck and LAT. The histogram represents the mean percentage   ±   
SEM of Lck into the membrane insoluble fraction. Three independent experiments were performed. (D) Cells were conjugated to SEE-pulsed APCs for 
15 min. After cell fi  xation, the distribution of Lck was analyzed. The histogram represents the mean percentage of Jurkat cells in T cell  –  APC conjugates 
with polarized distribution of Lck to the IS as quantifi  ed in three independent experiments.   n     >   100 T cells/experiment. (E) Lysates of normal Jurkat cells or 
Jurkat cells stably expressing MAL/myc cells were immunoprecipitated with anti-myc mAb, and the immunoprecipitates and the original lysates were 
analyzed by immunoblotting with antibodies to the c-myc tag or to Lck as indicated (left). Normal COS-7 cells or COS-7 cells transiently coexpressing 
MAL/myc and Lck-GFP, Lck  10  -GFP, p75-GFP, or GFP were lysed and immunoprecipitated with anti-myc or GFP antibodies. The immunoprecipitates and the 
original lysates were fi  nally analyzed by immunoblot with anti-myc and anti-GFP antibodies as indicated (right). Bars, 5   μ  m.     3206 A NOVEL PATHWAY FOR LCK EXOCYTOSIS IN T CELLS   | Ant  ó  n et al. 
.jem.org/cgi/content/full/jem.20080552/DC1) show that al-
though formation of Lck exocytic vesicles occurred in MAL-
expressing cells, this process was almost completely blocked 
in JTIM cells.   Only a very small number of much smaller 
vesicles were sporadically detected in JTIM cells. As a con-
trol, we observed that JTIM cells, although unable to transport 
Lck to the plasma membrane, were active in the formation of 
transport vesicles containing the transmembrane protein p75 
or the tyrosine kinase Fyn (  Fig. 6 B   and Videos 5 and 6). 
Consistent with these observations, unlike MAL and Lck, 
which colocalized extensively, Fyn and p75 showed a much 
plasma membrane (  Fig. 5 C   and Video 1, available at http://
www.jem.org/cgi/content/full/jem.20080552/DC1). The 
colocalization plot of MAL and Lck shows a high level of co-
localization between both proteins throughout the time-lapse 
experiment. The Pearson  ’  s correlation coeffi   cient  and  the 
overlap coeffi   cient according to Manders (  22  ) were 0.945 
and 0.954, respectively. 
  To examine the requirement of MAL for the formation 
of the Lck transport vesicles, we compared the dynamics of 
Lck at the perinuclear accumulation in the three types of Jur-
kat cell.   Fig. 6 A   and Videos 2  –  4 (available at http://www
    Figure 4.         Forced expression of Lck at the plasma membrane in MAL-defi  cient cells corrects TCR targeting to the IS.   JTIM cells were transfected 
with the CD4/Lck or the LAT/Lck plasmids. After 48 h at 37  °  C, cells were conjugated to SEE-loaded Raji cells for 20 min and fi  xed. Transfected cells were de-
tected with antibodies to mouse CD4 or to the c-Myc tag to detect expression of the CD4/Lck or LAT/Lck chimeras, respectively. (A) The distribution of TCR and 
MTOC was determined by immunofl  uorescence analysis. In the case of MTOC analysis, the contour of the cells has been drawn with a dotted line to facilitate 
the identifi  cation of the cells. The arrows indicate the position of the TCR or MTOC in the T cells expressing the chimera. (B) The distribution of ICAM-3, ZAP-
70, and PKC-     was determined by immunofl  uorescence analysis. Conjugates in A and B formed by untransfected JTIM cells serve as internal controls. Bars, 
5   μ  m. (C) Quantitative analysis of the polarization of TCR, MTOC, ZAP-70, and PKC-     in JTIM cells expressing the CD4/Lck or LAT Lck chimeras. Three indepen-
dent experiments were performed.   n     >   100 T cells/experiment. The histogram shows the mean percentage   ±   SEM of APC conjugates with TCR, MTOC, ZAP-70, 
or PKC-     polarized to the IS. (D and E) Jurkat cells and JTIM cells transfected or not with the CD4/Lck or LAT/Lck chimeras were transfected with CD4   Cyt-
GFP (D) or pEGFP-C1 (E) and treated with activating anti-CD3 antibodies or PMA as indicated. After 15 min (D) or 16 h (E) at 37 ° C,  EGFP-expressing  cells  were 
analyzed for phosphorylated Erk (D) or CD69 (E) expression by fl  ow cytometry. The cotransfection effi  ciency was   >  80% as determined by immunofl  uorescence 
microscopy. The histograms shows the percentage   ±   SEM of the mean fl  uorescence of phospho-Erk and CD69 obtained in each case relative to that of Jurkat 
cells stimulated with anti-CD3 antibodies. Three independent experiments were performed.    JEM VOL. 205, December 22, 2008 
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p75 and 0.752 and 0.546 for MAL/Fyn. We conclude from 
this set of experiments that MAL colocalizes extensively with 
Lck at steady state, is present in the same transport carriers 
that contain Lck, and is essential for the formation of such 
specifi  c carriers. 
  MAL is essential for activation-induced AP-1, NF-    B, 
and NFAT activities and for tyrosine phosphorylation 
in Jurkat cells 
  Because the JTIM cell clone was isolated as defective in 
TCR-mediated signaling, we investigated whether exogenous 
expression of MAL rescued the signaling defect by analyzing 
the eff  ect of MAL expression in various signaling cascades in-
duced by TCR stimulation. We fi  rst compared the activation 
of the mitogen-activated protein kinase Erk, p38, and JNK 
pathways, which lead to increased AP-1 activity, in the three 
Jurkat cell systems used that were stimulated with SEE (  Fig. 
7 A  , left).   Erk activation was detected in normal Jurkat cells 
but not in JTIM cells. Reconstitution of MAL in JTIM cells 
rescued Erk activation. In contrast to Erk, activation of p38 
and JNK kinases was less aff  ected in JTIM cells. Because AP-1 
activity is regulated by Erk, JTIM cells were, as expected, de-
fi  cient in their ability to stimulate AP-1 activity (  Fig. 7 A  , 
right). The activation state of the NF-    B pathway was exam-
ined by analyzing the phosphorylation of the IKK-    /     sub-
units of IKK, a hallmark of the NF-    B activation pathway 
(  Fig. 7 B  , left). Similar to the case of Erk, JTIM cells were 
unable to induce IKK-    /     phosphorylation, whereas normal 
phosphorylation occurred in JTIM/MAL cells. The impair-
ment of IKK-    /     phosphorylation in JTIM, but not in WT 
Jurkat or MAL-expressing JTIM cells, was associated with 
the inhibition of NF-    B activity (  Fig. 7 B  , right). The func-
tionality of the NFAT activation pathway was addressed by 
analyzing the dephosphorylation of NFAT, which is a step 
required for NFAT activation (  Fig. 7 C  , left). This process 
was equally functional in normal Jurkat cells and JTIM/MAL 
cells even though it did not occur in JTIM cells. Consistent 
with this result, induction of NFAT transcriptional activity 
was impaired in JTIM cells compared with observations in 
the two types of MAL-expressing Jurkat cell (  Fig. 7 C  , right). 
Finally, we noticed that tyrosine phosphorylation of CD3  	  , 
ZAP-70, and PLC-    1 in response to stimulation was defec-
tive in the absence of MAL but normal in the two types of 
MAL-expressing Jurkat cell, even though the three types of 
Jurkat cell that we used expressed similar levels of the three 
proteins (  Fig. 7 D  ). 
  Next, we analyzed whether, in addition to restoring AP-1, 
NF-    B, and NFAT responses to stimulation, exogenous 
MAL expression in JTIM cells was able to do the same with 
the transcriptional activation of the IL-2 promoter.   Fig. 7 E   
shows that JTIM/MAL cells responded to SEE stimulation 
by activating IL-2 promoter-driven transcription at levels 
similar to those of normal Jurkat cells, whereas JTIM cells 
were basically unresponsive. As a control, we observed that 
all three cells were able to respond to stimulation with PMA 
plus ionomycin, indicating that this treatment bypasses the 
lower colocalization with MAL (  Fig. 6 C  ). The Pearson  ’  s 
correlation coeffi   cient and the overlap coeffi   cient according 
to Manders were 0.710 and 0.740, respectively, for MAL/
    Figure 5.         Lck and MAL travel in the same transport vesicles des-
tined for the plasma membrane.   (A) Jurkat cells stably expressing GFP-
MAL were subjected to double label immunofl  uorescence analysis to 
detect GFP-MAL and endogenous Lck. (B) Cells were transfected with Lck-
GFP and the distribution of Lck-GFP was analyzed 20 h later. A densito-
metric analysis of the distribution of Lck-GFP along the line in each type 
of cell is shown on the right panels. Arrows indicate the position of the 
periphery of the cell. (C) Jurkat cells stably expressing GFP-MAL were 
transiently transfected with plasmid DNA expressing Lck-Cherry and sub-
jected to time-lapse videomicroscopy. The processes occurring within the 
region indicated by the dashed square are shown at higher magnifi  cation 
in the bottom panels. Solid and empty arrowheads indicate two vesicles 
transporting MAL and Lck together to the plasma membrane. Numbers 
indicate time in seconds. The plot on the right shows a high correlation of 
the colocalization of MAL and Lck throughout the time-lapse experiment 
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MAL defect in JTIM cells. Collectively, the results in   Fig. 7   
show that the sole expression of MAL in JTIM cells is suffi   -
cient to restore the signaling pathways controlling transcrip-
tional activation of the IL-2 promoter. 
    DISCUSSION   
  The use of siRNA silencing techniques both in Jurkat and 
primary T cells and the isolation of a Jurkat cell variant lack-
ing MAL expression allowed us to address the role and mech-
anism of action of MAL in T cells. Conjugates with APC 
were effi   ciently formed using MAL-depleted T cells, but 
TCR, Lck, ZAP-70, and PKC-     did not redistribute to the 
IS. The requirement for MAL for IS formation was confi  rmed 
in T cell  –  APC conjugates formed in the presence of the SEB 
superantigen or a specifi  c HA peptide. In addition to defi  -
cient IS formation, MAL-depleted cells were unable to activate 
signaling pathways leading to up-regulation of IL-2 promoter 
transcription in response to SEE and showed reduced levels 
of Lck at the cell periphery. All these defects were corrected 
by exogenous expression of MAL. Therefore, our results es-
tablish the requirement for MAL in the processes of IS for-
mation and T cell activation. 
  Given the crucial role of MAL as an element of the spe-
cialized machinery for apical transport in epithelial cells (  12  –  14, 
23  ), an obvious aspect of interest concerning MAL function 
in T cells was its involvement in specialized membrane traf-
fi  cking to the cell surface (  15, 24  ). During our search for 
abnormally distributed plasma membrane proteins in MAL-
defi  cient cells, we found that although Lck was distributed at 
both the cell periphery and in endosomes in normal Jurkat 
cells, Lck was practically absent from the plasma membrane 
and instead was concentrated in a compact intracellular struc-
ture in Jurkat cells lacking MAL expression. It is of particular 
note that Lck distributed normally when MAL levels were 
reconstituted by exogenous expression. Consistent with these 
fi  ndings, knockdown of MAL levels in primary T cells re-
duced the presence of Lck at the plasma membrane with 
concomitant intracellular accumulation compared with the 
exclusive peripheral expression of Lck in control cells. There-
fore, MAL appears to be crucial for normal targeting of Lck 
to the T cell surface. 
  Lck is known to rely on membrane-traffi   cking mecha-
nisms for targeting to the cell surface (  6  ). Expression of Lck 
at the plasma membrane is essential for T cell function be-
cause Lck mutants that are unable to reach the plasma mem-
brane are defective in T cell signaling (  7  ). The presence of a 
pool of Lck in endosome structures and their colocalization 
with MAL in normal Jurkat cells are consistent with a possi-
ble role for MAL in Lck exocytosis. This view was supported 
by our observations of time-lapse videomicroscopy in living 
cells, in which Lck and MAL traveled in the same vesicles 
    Figure 6.         MAL is required for formation of vesicles transporting 
Lck to the plasma membrane.   (A) WT Jurkat cells, JTIM cells, or JTIM/
MAL cells were transiently transfected with plasmid DNA expressing Lck-
GFP and monitored by time-lapse videomicroscopy to detect the forma-
tion of Lck-containing transport vesicles. The contour of the JTIM cell 
transfected with Lck-GFP has been drawn with a continuous line to indi-
cate the position of the plasma membrane. (B) A similar analysis was done 
in JTIM cells transiently expressing p75-GFP and Fyn-GFP. The processes 
occurring within the regions indicated by the dashed squares are shown 
at higher magnifi  cation on the right. Filled and empty arrowheads indi-
cate vesicles transporting Lck, p75, or Fyn. Numbers indicate time in sec-
onds. Bars, 5   μ  m. (C) Jurkat cells stably expressing Cherry-MAL were 
transiently transfected with plasmid DNA expressing p75-GFP or Fyn-GFP 
and subjected to time-lapse videomicroscopy. Colocalization plots of MAL 
and p75 or Fyn throughout the time-lapse experiment are shown. Pear-
son ’ s  correlation  coeffi  cients were 0.710 and 0.752 for MAL/p75 and MAL/
Fyn,  respectively.   
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destined for the cell surface. The vesicles were large and 
formed discontinuously. It is worth noting that the formation 
of the vesicles containing Lck was impaired in the MAL-de-
fi  cient Jurkat variant, and only a few much smaller vesicles 
were sporadically formed. The absence of MAL did not pro-
voke a general block on the generation of transport vesicles 
because vesicles containing Fyn-GFP or p75-GFP formed ef-
fi  ciently in JTIM cells. Our results indicate that MAL medi-
ates a specialized route of transport in T cells that is used for 
targeting Lck to the plasma membrane. 
  Membrane microdomains were originally postulated as 
being specialized platforms for apical transport (  8  ). Although 
controversial (  25  ), it is sometimes assumed that the mem-
brane fraction resistant to detergent solubilization is enriched 
in membrane microdomains (  26, 27  ). Approximately 30  –  50% 
of Lck is isolated in detergent-insoluble membrane fractions 
(  28, 29  ). Consistent with the observed colocalization of MAL 
and Lck in endosome structures in Jurkat cells, both proteins 
cofractionate in a detergent-insoluble subendosomal mem-
brane fraction (  11  ). It is of particular note that the inability of 
Lck to reach the plasma membrane in MAL-defi  cient Jurkat 
cells is associated with its exclusion from detergent-insoluble 
membrane fractions. Similar to the strict link between plasma 
membrane targeting and detergent insolubility for Lck found 
in WT, MAL-defi  cient, and MAL-reconstituted Jurkat cells, 
polarized apical targeting of HA in Mardin-Darby canine 
kidney cells is associated with HA insolubility in a MAL ex-
pression  –  dependent manner (  12  ). This latter observation, to-
gether with the association found between MAL and HA, 
was interpreted as meaning that one of MAL  ’  s functions is to 
recruit HA to membrane platforms for apical exocytosis 
(  12, 20  ). Consistent with this view, the transport defect ob-
served for Lck in the absence of MAL expression may be ex-
plained by a membrane alteration that prevents incorporation 
of Lck into specifi  c membrane platforms acting in Lck exo-
cytosis. Because MAL associates with Lck and exogenous ex-
pression of MAL fully restored not only the blocking of the 
partitioning into detergent-insoluble membranes but also the 
transport of Lck, it might be that a primary function of MAL 
in T cells is to recruit Lck to specialized membranes involved 
in the formation of transport carriers and the subsequent tar-
geting of Lck to the plasma membrane. 
  In addition to the redistribution of receptors and sig-
naling machinery, IS formation implies recruitment of actin 
    Figure 7.         Signaling pathways of Jurkat cells leading to activation 
of AP-1, NF-    B, and NFAT and to induced tyrosine phosphorylation 
are dependent on MAL expression.   (A) The three types of Jurkat cell 
were conjugated to APCs pulsed with SEE for the indicated times. Cell 
extracts were analyzed by immunoblotting to detect the activated, phos-
phorylated (p) forms or the total content of Erk, p38, and JNK as indicated 
(left). Cells were transfected with a luciferase reporter plasmid whose 
transcription was controlled by AP-1. Cells were then conjugated to APCs, 
which were pulsed or not with SEE. After 4 h, luciferase activity was mea-
sured (right). (B) The three types of Jurkat cell were conjugated for the 
indicated times to APCs pulsed with SEE. Cell extracts were analyzed by 
immunoblotting to detect the activated phosphorylated forms of IKK-   /   
or the total content of IKK-     (left). Cells were transfected with a lucifer-
ase reporter plasmid whose transcription was controlled by NF-   B.  Cells 
were then conjugated to APCs, which were pulsed or not with SEE. After 
4 h, luciferase activity was measured (right). (C) Cells were conjugated to 
APCs pulsed with SEE for 1 h at 37  °  C. Cell extracts were analyzed by 
immunoblotting with anti-NFAT antibodies that detect both the inactive 
phosphorylated NFAT and the active dephosphorylated NFAT forms. Con-
trol of cells treated for 1 h with PMA plus ionomycin (Io) in the absence 
or presence of cyclosporin A (CsA) was included to help identifi  cation of 
phosphorylated and dephosphorylated NFAT (left). The three types of 
Jurkat cell were transfected with a luciferase reporter plasmid whose 
transcription was controlled by NFAT. Cells were then conjugated to APCs, 
which were pulsed or not with SEE. After 4 h, luciferase activity was mea-
sured (right). (D) Cells were treated or not with activating anti-CD3 
UCHT1 antibodies for 15 min. Cell extracts were immunoprecipitated with 
antiphosphotyrosine PY20 mAb coupled to agarose. The phosphotyrosine 
immunoprecipitates were immunoblotted to detect tyrosine phosphory-
lated CD3  	  , ZAP-70, and PLC-    1 (top). The original extracts were immuno-
blotted to show the total content of CD3  	  , ZAP-70, and PLC-   1  (bottom). 
(E) The three types of Jurkat cell were transiently transfected with plasmid 
DNA containing the luciferase gene under the control of the IL-2 pro-
moter. After 16 h, cells were conjugated to APCs, which were pulsed or 
not with SEE (top), or incubated or not with PMA plus ionomycin (Io; 
bottom). After 4 h, cell extracts were used to determine luciferase activity. 
Data are represented as mean   ±   SEM of the luciferase activity in stimu-
lated cells relative to that in unstimulated cells.     
 3210 A NOVEL PATHWAY FOR LCK EXOCYTOSIS IN T CELLS   | Ant  ó  n et al. 
bly mediated by correction of the abnormal targeting of Lck, 
and probably of other signaling molecules, that is observed in 
the absence of MAL expression. 
  A constitutive MAL KO mouse line was generated to in-
vestigate the role of MAL on myelin formation (  38  ). The 
mice were viable, had a normal life span, and appeared grossly 
normal. However, a closer inspection revealed defects in 
axon  –  glia interactions. Importantly, although MAL is ex-
pressed in oligodendrocytes and Schwann cells, alterations 
were observed only in the central nervous system, whereas 
the peripheral nervous system did not seem to be aff  ected. 
The possible existence of a compensatory mechanism of an-
other as yet unknown MAL family protein was claimed that 
might replace the functional role of endogenous MAL at the 
peripheral nervous system. Unlike humans, thymus, primary 
T cells, and T cell lines of mouse origin do not express the 
  MAL   gene. The most plausible explanation is that another 
member of the MAL protein family or of the MARVEL do-
main  –  containing protein superfamily does the job in mouse T 
cells. This reminds us of the caution that must be exercised in 
making defi  nitive assignments of physiological function across 
species. Although animal models are undoubtedly quite useful 
for biomedical research, it is clear that studies in human cells 
need to be performed to learn about human cell functioning. 
  Progress in understanding MAL function as a component 
of the machinery for specialized routes of protein transport was 
fi  rst made possible in epithelial cells by taking advantage of the 
seminal discoveries made in epithelial cells concerning protein 
sorting (  39  ). In this study, using gene silencing in Jurkat T cells 
and primary human T lymphocytes, and a Jurkat cell clone 
with defi  cient MAL expression, we have found an essential 
role for MAL in exocytic transport of Lck to the plasma mem-
brane. In addition, our results highlight the similarity of the 
Lck transport process of T cells to that of the specialized MAL-
mediated apical route of protein exocytosis of polarized 
epithelial cells. Normal functioning of this novel transport 
pathway is essential for T cell activation and IS formation. 
  MATERIALS AND METHODS 
  Materials.     Rabbit antibodies to CD3  	   and ZAP-70, and mAb UCHT-1 
(IgG1) and APA 1.1 to CD3 (used for cell activation and immunoblot analy-
sis, respectively), were provided by A. Alarc  ó  n (Centro de Biolog  í  a Molec-
ular   “  Severo Ochoa  ”  , Madrid, Spain). Rabbit polyclonal antibody to Lck 
(used for immunofl  uorescence analysis) was provided by A. Veillette (McGill 
University, Montreal, Canada). Mouse mAb MEM-43/5 to CD59 was 
a gift from V. Horejsi (Institute of Molecular Genetics, Prague, Czech Re-
public); mAbs to PLC-    1 and PKC-     and the antiphosphotyrosine PY20 
antibodies, coupled or not to agarose, were obtained from BD; mouse hy-
bridomas producing anti-CD3  
   mAb OKT3 and anti-Myc mAb 9E10 were 
purchased from the American Type Culture Collection; and antibodies to 
LAT were obtained from Millipore. Antibodies to total or phosphorylated 
Erk and p38 used for immunoblotting were obtained from Promega and 
Santa Cruz Biotechnology, Inc., respectively. The anti-JNK and anti  –  IKK-
    /     antibodies were purchased from Cell Signaling Technology. The anti-
bodies to NFAT, ICAM-3, and mouse CD4 were provided by J.M. 
Redondo (Centro de Biolog  í  a Molecular   “  Severo Ochoa  ”  , Madrid, Spain), 
F. S  á  nchez-Madrid (Hospital de la Princesa, Madrid, Spain), and J.M. Rojo 
(Centro de Investigaciones Biol  ó  gicas, Madrid, Spain), respectively. Anti-
bodies to     -tubulin, talin, and GFP were obtained from Sigma-Aldrich. We 
cytoskeleton elements, which form a specialized network of 
actin fi  laments while retaining their apparently normal sub-
cortical organization in the rest of the cell membrane, and re-
positioning of MTOC, which controls the position of the 
secretory and endocytic compartments toward the IS (  30  ). 
Repositioning of these compartments could have consequences 
on the activation process that could bring Fyn, Pyk2, and 
other signaling molecules closer to IS (  31  ). It has also been 
reported that a pool of Lck and LAT that is associated with 
recycling endosomes translocates to mature synapses (  32, 33  ). 
Therefore, the absence of MTOC reorientation in MAL-de-
fi  cient cells probably aff  ects polarized targeting from the se-
cretory/endocytic compartments to IS (  32  –  34  ). 
  Both actin and talin redistributed to the IS regardless of 
whether MAL was expressed, implying that MAL is not re-
quired for this process. Remarkably, unlike the TCR, which 
required MAL for IS targeting, ICAM-3 was normally re-
cruited in the absence of MAL. This indicates that ICAM-3 
targeting to IS takes place by MAL-independent mechanisms 
that are most probably linked to the actin cytoskeleton rear-
rangement. In this regard, association of ICAM-3 with ERM 
proteins has been previously documented (  35  ). In contrast to 
the remodeling of the actin cytoskeleton, the MTOC did not 
reorient to the IS in the absence of MAL. MTOC reorienta-
tion is impaired in Lck- or ZAP-70  –  defi  cient Jurkat cells (  36  ) 
and requires phosphorylation in tyrosine of immunoreceptor 
tyrosine-based activation motifs that are present at the cyto-
plasmic tail of the CD3 subunits (  37  ). To analyze whether 
the absence of Lck at the plasma membrane can by itself fully 
account for the failure to trigger the signals required for 
proper IS formation, we forced the expression of Lck at the 
plasma membrane by expression of CD4/Lck and LAT/Lck 
transmembrane chimeras in JTIM cells. It is of particular note 
that the chimeras were able to restore the targeting of TCR, 
ZAP-70, and PKC-     to IS, indicating that these transmem-
brane forms of Lck, regardless of their level of partitioning 
into detergent-insoluble membranes, were equally able to ini-
tiate TCR-induced signaling even in the absence of MAL 
expression. Despite this, however, both chimeras did not 
correct MTOC reorientation or TCR-induced downstream 
signaling events such as ERK activation and CD69 up-regu-
lation. These fi  ndings indicate that the defi  cient targeting of 
Lck to the plasma membrane is not the sole cause of the ef-
fects observed in MAL-defi  cient cells and implies that, in ad-
dition to transporting Lck, MAL mediates other functions in 
the cell, probably related to the transport of other specifi  c 
molecules and the repositioning of the MTOC. 
  Jurkat cells lacking MAL expression were unable to acti-
vate transcription of the IL-2 promoter in response to stimu-
lation with SEE. Consistent with this observation, the signaling 
pathways leading to activation of transcription factors AP-1, 
NF-    B, and NFAT, or to increased tyrosine phosphorylation 
of specifi  c substrates, were defective. Reconstitution of MAL 
levels by exogenous expression made these pathways fully 
operative and rescued normal response of the IL-2 promoter 
to T cell stimulation. Restoration of these pathways is proba-JEM VOL. 205, December 22, 2008 
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  Generation, characterization, and reconstitution of a Jurkat cell 
mutant defective in MAL expression.     The JTIM cell line was generated 
by chemical mutagenesis using methanesulfonic acid ethyl ester (EMS; 
Sigma-Aldrich) and selection for clones that were defective in TCR-in-
duced signaling in a manner that is similar to that previously described for 
PMA-induced up-regulation (  19  ). The defi  ciency in MAL was identifi  ed by 
a comparison of genes expressed in parental Jurkat and JTIM using DNA 
microarrays, as described for other mutant Jurkat cell lines (  18  ). JTIM cells 
were provided by A. Weiss (University of San Francisco, San Francisco, 
CA). Sometimes the JTIM cells were suddenly able to recover MAL expres-
sion spontaneously in a manner that could not be controlled. This probably 
involves changes in the methylation state of the MAL gene because treat-
ment with the demethylating agent 5-aza-2  ’  -deoxycytidine is able to recover 
MAL gene expression in these cells (unpublished data) as well as in certain 
tumor cells in which the MAL gene is silent (  47  ). To circumvent this prob-
lem, the absence of MAL expression was checked in parallel by immuno-
blotting to validate all the experiments done with JTIM cells. 
  To reconstitute expression with exogenous MAL, JTIM cells were 
transfected with a pCR3.1 DNA construct (Invitrogen) containing a 0.8-kb 
EcoRI  –  XhoI MAL cDNA fragment, which encompasses the 5     untranslated 
region, the entire MAL coding region, and part of the 3  ‘   untranslated se-
quences of MAL mRNA. After selection with 1 mg/ml G-418 sulfate for at 
least 6 wk after transfection, drug-resistant cell clones were screened for 
MAL expression by immunoblot analysis with anti-MAL mAb 6D9. All the 
reconstituted clones that were obtained expressed MAL at similar levels. The 
cell clones positive for MAL expression were thereafter maintained in drug-
free medium. Although all the results presented in this contribution were 
obtained using the same JTIM/MAL cell clone, two other reconstituted 
clones were analyzed to confi  rm our main fi  ndings. Jurkat cells stably ex-
pressing MAL/myc, MALmut/myc, or GFP-MAL were generated accord-
ing to a similar protocol. 
  Flow cytometry.     For analysis of CD69 up-regulation, Jurkat cells and 
JTIM cells were transfected with pEGFP and, in the case of JTIM cells, co-
transfected or not with the chimeras expressing CD4/Lck or LAT/Lck. Af-
ter 24 h, cells were stimulated or not with 10   μ  g/ml of anti-CD3 antibodies 
or 50 ng/ml PMA. The GFP-expressing cell population was analyzed 16 h 
later for the expression of surface CD69 with fl  uorescent anti-CD69 anti-
bodies (Invitrogen) in a FACSCalibur fl  ow cytometer using CellQuest Pro 
software (BD). For analysis of Erk phosphorylation, normal Jurkat cells and 
JTIM cells were transfected with CD4    Cyt-GFP and, in the case of JTIM 
cells, cotransfected or not with the chimeras expressing CD4/Lck or LAT/
Lck. After 24 h, cells were stimulated or not with anti-CD3 antibodies or 
PMA for 15 min and then were fi  xed with 2% paraformaldehyde and per-
meabilized with methanol at     20  °  C. Phosphorylated Erk was analyzed in 
the cell population expressing CD4    Cyt-GFP using anti  –  phospho-Erk rab-
bit antibodies (Cell Signaling Technology) and a secondary fl  uorescent anti  –
  rabbit Ig antibody. The use of CD4    Cyt-GFP facilitates the identifi  cation of 
the transfected cell population as the fl  uorescence of this transmembrane 
chimera is retained in fi  xed permeabilized cells to a greater extent than using 
just GFP. The cotransfection effi   ciency was   >  80% as determined by immuno-
fl  uorescence microscopy. The mean fl  uorescence intensity obtained in each 
case for CD69 or phospho-Erk was compared with that obtained for normal 
Jurkat cells stimulated with anti-CD3 antibodies, which was taken as 100%. 
Controls to assess the specifi  city of the labeling included incubations with 
control primary antibodies or omission of the primary antibodies. 
  Luciferase reporter assays.     Jurkat cells were transiently transfected using 
Lipofectamine (Promega) with plasmid DNA (150 ng/1.0   ×   10  6   cells) con-
taining the fi  refl  y luciferase gene under the control of IL-2 promoter, AP-1, 
NF-    b, or NFAT responsive elements and with a renilla luciferase reporter 
plasmid (Promega). Jurkat cells were then conjugated with Raji B cells in the 
presence or absence of SEE for 4 h or activated with anti-CD3 antibodies 
or with 20 ng/ml PMA plus 5   μ  M ionomycin for 4 h. Aliquots of cell ly-
sates were analyzed for luciferase activity with the Dual Luciferase Reporter 
Assay kit according to the manufacturer  ’  s protocol (Promega). The protein 
obtained SEE and SEB from Toxin Technology, Inc. HRP-conjugated an-
tibodies were obtained from Thermo Fisher Scientifi  c. Fluorochrome-la-
beled secondary goat antibodies, fl  uorescent phalloidin, and the fl  uorescent 
cell tracker chloromethyl derivative of aminocoumarin (CMAC) were pur-
chased from Invitrogen. 
  Cell culture conditions and conjugate formation procedure.     Human 
T lymphoblastoid Jurkat cells were grown in RPMI 1640 supplemented 
with 5% FBS (Sigma-Aldrich), 50 U/ml penicillin, and 50   μ  g/ml strepto-
mycin at 37  °  C in an atmosphere of 5% CO  2  /95% air. To distinguish Raji 
cells from Jurkat cells in the conjugates, Raji cells (3.0   ×   10  6   cells/ml) were 
preincubated with 10   μ  M CMAC for 20 min at 37  °  C, washed, and resus-
pended in RPMI/5% FBS. The cells were then incubated for 20 min in the 
presence or absence of 4   μ  g/ml SEE and mixed with an equal number of 
Jurkat cells (5.0   ×   10  5   cells/well) in a fi  nal volume of 50   μ  l, incubated at 
37  °  C for 15 min, and plated onto poly-  l  -lysine  –  coated slides. After incuba-
tion for 15 min at 37  °  C, cells were fi  xed with formalin, permeabilized or 
not, blocked with 3% BSA and 100   μ  g/ml     -globulin, and stained with the 
appropriate antibodies. Jurkat CH7C17 cells (  21  ) expressing exogenous 
TCR-     and TCR-     (V    3) chains specifi  c for HA were conjugated to 
HOM2 cells in the presence of 200   μ  g/ml HA peptide 307  –  319 
(PKYVKQNTLKLAT), a control inactive peptide (PKYVKQNTLELAT), 
or 4   μ  g/ml SEB. For conjugation of primary T cells, freshly isolated T lym-
phocytes from healthy donors were incubated with SEE-pulsed Raji cells 
and processed as described for the Jurkat  –  APC conjugates. The experiments 
with human cells were done according to the guidelines of the Bioethics 
Committee of the Spanish Research Council and were approved by the in-
stitutional Management Committee of the Centro de Biolog  í  a Molecular 
  “  Severo Ochoa  ”  . 
  DNA constructs and transfection conditions.     The 5    -TCATG-
GCCCCCGCAGCGGC-3     and 5    -GGGAGCTTGCTGTGTCTAA-3     
sequences, which target the sequences surrounding the AUG translation ini-
tiation site and the 3     untranslated region of MAL mRNA, respectively, sepa-
rated by a short spacer (5   -TTCAAGAGA-3    ) from their reverse complement, 
were cloned under the control of the H1-RNA promoter in the pSUPER 
DNA vector (  40  ) thereby originating the pMAL-siRNA1 and pMAL-
siRNA2 constructs. These plasmids were then modifi  ed by insertion of a 
DNA fragment containing the GFP coding sequence under the control of the 
CMV immediate-early promoter generating the pMAL-siRNA1/GFP and 
pMAL-siRNA2/GFP constructs. A similar construct containing a target-rec-
ognition sequence corresponding to BENE mRNA, which is not expressed 
in T cells (  41  ), was used as a control. The DNA constructs expressing the 
ectodomain and transmembrane region of mouse CD4 fused to Lck (CD4/
Lck) (  42  ) or to GFP (CD4    Cyt-GFP) (  43  ) were gifts from A. Weiss (Uni-
versity of San Francisco, San Francisco, CA) and M.F. Krummel (University 
of San Francisco, San Francisco, CA), respectively. The CD4/Lck construct 
was used to generate a LAT/Lck construct by excising the CD4 sequences 
and substituting them by the LAT sequences encoding the fi  rst 36 aa of the 
amino terminus of LAT, which included its extracellular and transmembrane 
domains. Sequences encoding the c-Myc tag were fi  nally added to the LAT/
Lck coding sequence. The plasmid expressing p75-GFP in pEGFP-N1 (  44  ) 
was a gift from E. Rodriguez-Boulan (Cornell University, Ithaca, NY). The 
Fyn-GFP construct (  45  ) and the Lck  10  -GFP construct expressing the fi  rst 10-aa 
sequence of Lck fused to the amino terminus of GFP (  46  ) were generously 
provided by N. Yamaguchi (Chiba University, Chiba, Japan) and W. Rodg-
ers (Oklahoma Medical Research Foundation, Oklahoma City, OK), respec-
tively. The DNA constructs expressing GFP or Cherry appended to the 
carboxyl terminus of Lck (Lck-GFP and Lck-Cherry) or the amino terminus 
of MAL (GFP-MAL and Cherry-MAL) were made by standard techniques. 
Jurkat cells and primary human T cells were transfected by electroporation 
using the Gene Pulser system (Bio-Rad Laboratories). As controls of the 
siRNA experiments, we used Jurkat cells stably expressing N-terminal Myc-
tagged MAL proteins with either an intact (RWKSS, MAL/myc) or a modi-
fi  ed (RWSSS, MALmut/myc) MAL carboxyl terminus encoded by mRNAs 
that do not fully pair with the MAL siRNA used (  20  ). 3212 A NOVEL PATHWAY FOR LCK EXOCYTOSIS IN T CELLS   | Ant  ó  n et al. 
total membrane fractions. Video 1 shows time-lapse microscopy showing 
MAL and Lck in the same transport carriers destined for the plasma mem-
brane. Videos 2  –  4 show time-lapse microscopy of Lck in Jurkat, JTIM, and 
JTIM/MAL cells, respectively. Videos 5 and 6 show time-lapse microscopy 
of p75 and Fyn, respectively, in JTIM cells. Online supplemental material is 
available at http://www.jem.org/cgi/content/full/jem.20080552/DC1. 
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